Plumbagin inhibits prostate cancer development in TRAMP mice via targeting PKCε, Stat3 and neuroendocrine markers
about
Plumbagin attenuates cancer cell growth and osteoclast formation in the bone microenvironment of mice.Antiproliferative effects of Plumbago rosea and its purified constituent plumbagin on SK-MEL 28 melanoma cell lines.TRAMP prostate tumor growth is slowed by walnut diets through altered IGF-1 levels, energy pathways, and cholesterol metabolism.Chemopreventive Effects of Korean Angelica versus Its Major Pyranocoumarins on Two Lineages of Transgenic Adenocarcinoma of Mouse Prostate CarcinogenesisThe Multifaceted Roles of STAT3 Signaling in the Progression of Prostate Cancer.Anticancer Properties and Pharmaceutical Applications of Plumbagin: A Review.Plumbagin, a medicinal plant (Plumbago zeylanica)-derived 1,4-naphthoquinone, inhibits growth and metastasis of human prostate cancer PC-3M-luciferase cells in an orthotopic xenograft mouse model.Plumbagin Inhibits Prostate Carcinogenesis in Intact and Castrated PTEN Knockout Mice via Targeting PKCε, Stat3, and Epithelial-to-Mesenchymal Transition Markers.Plumbagin exhibits an anti-proliferative effect in human osteosarcoma cells by downregulating FHL2 and interfering with Wnt/β-catenin signalling.Oral administration of withaferin A inhibits carcinogenesis of prostate in TRAMP model.Biphasic augmentation of alpha-adrenergic contraction by plumbagin in rat systemic arteries.Plumbagin improves the efficacy of androgen deprivation therapy in prostate cancer: A pre-clinical study.Differential gene expression induced by anti-cancer agent plumbagin is mediated by androgen receptor in prostate cancer cells.Protein kinase D1 regulates subcellular localisation and metastatic function of metastasis-associated protein 1.Oxidative Phosphorylation: A Target for Novel Therapeutic Strategies Against Ovarian CancerProtein Kinase C (PKC) Isozymes and Cancer
P2860
Q33823691-D811D375-210C-4924-8359-F17166FAA59DQ34201413-70F26C5F-C02E-4604-A7F0-4DD6E38EB86AQ34652483-7505E7BE-5D93-4954-B69F-BEF51F06F208Q36288473-9F836CB6-DEE8-4079-9AD5-59C5F979D968Q38203779-677EE859-ACEF-4F14-AD04-7847DA620E06Q39209049-36B596E9-DB39-4D84-B20B-3223F686F98FQ39219294-BBACCBC3-035E-4B14-8C69-1FB9B7A3358EQ40185493-276E7FDD-166B-4815-8E45-D6F8E10195F7Q42051646-5D16C9EA-D1CA-4252-B9BE-67A8BBC67AB0Q42137006-9FD0709B-2419-4650-A69A-EB614D261DC3Q47102181-8C93CB45-BC4D-438A-80AB-5C5841810A7DQ48255570-8205E456-30B4-43C2-96FB-58EA9A2E5204Q49186848-5FAD962F-4277-4FD6-8D7A-36DDE716F7A0Q49716048-AD13AE7F-68C6-40E7-A717-6E309A366481Q58723357-11996DDB-BFC1-48CD-B181-4244157C37C2Q59072618-55E43674-7096-4EB2-B679-319DFC24824C
P2860
Plumbagin inhibits prostate cancer development in TRAMP mice via targeting PKCε, Stat3 and neuroendocrine markers
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Plumbagin inhibits prostate ca ...... at3 and neuroendocrine markers
@ast
Plumbagin inhibits prostate ca ...... at3 and neuroendocrine markers
@en
type
label
Plumbagin inhibits prostate ca ...... at3 and neuroendocrine markers
@ast
Plumbagin inhibits prostate ca ...... at3 and neuroendocrine markers
@en
prefLabel
Plumbagin inhibits prostate ca ...... at3 and neuroendocrine markers
@ast
Plumbagin inhibits prostate ca ...... at3 and neuroendocrine markers
@en
P2093
P2860
P356
P1433
P1476
Plumbagin inhibits prostate ca ...... at3 and neuroendocrine markers
@en
P2093
Ajit K Verma
Ala Mustafa
Bilal Bin Hafeez
Joseph W Fischer
Olya Witkowsky
Weixiong Zhong
P2860
P304
P356
10.1093/CARCIN/BGS291
P407
P577
2012-09-13T00:00:00Z